These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21736475)

  • 1. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
    Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
    Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
    Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999].
    Berger C; Trombert-Paviot B; Mitton N; Frappaz D; Galambrun C; Plantaz D; Dupuis S; Bertrand Y; Philippe N; Schell M; Marec-Bérard P; Bergeron C; Armari-Alla C; Pagnier A; Stephan JL; Freycon F
    Arch Pediatr; 2006 Feb; 13(2):121-9. PubMed ID: 16376530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
    Lacour B; Desandes E; Mallol N; Sommelet D
    Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long term mortality of five-year survivors of childhood cancer in Rhône-Alpes region].
    Trombert-Paviot B; Frappaz D; Casagranda L; Plantaz D; Bertrand Y; Stephan JL; Berger C; Freycon F
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):383-90. PubMed ID: 19013040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.
    Devarahally SR; Severson RK; Chuba P; Thomas R; Bhambhani K; Hamre MR
    Pediatr Hematol Oncol; 2003 Dec; 20(8):617-25. PubMed ID: 14578032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhône-Alpes region in France (ARCERRA).
    Freycon F; Trombert-Paviot B; Casagranda L; Bertrand Y; Plantaz D; Marec-Bérard P
    Pediatr Blood Cancer; 2008 Jun; 50(6):1213-20. PubMed ID: 18300318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
    Inskip PD
    Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
    Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.